Gossamer Bio (GOSS) Assets (2018 - 2026)
Gossamer Bio (GOSS) reported Assets of $76.87 million for Q2 2026, down 68.1% from $240.93 million a year earlier and down 40.4% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, Gossamer Bio posted Assets of $172.25 million, down 45.4% from FY2024.
- Assets has a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
- By year, Assets came in at $315.29 million in FY2024 (+1.1%), $311.92 million in FY2023 (+14.5%), $272.45 million in FY2022 (-20.7%) and $343.66 million in FY2021 (-36.3%).
- The Q2 2026 figure ranks as the lowest quarterly Assets in data going back to Q4 2018.
- Year over year, Assets has now declined in each of the last five quarters, with an average decline of 29.2% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2024 (growth of 105.5%); the low point was Q2 2026 (a decline of 68.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $128.9 million (Q1 2026), $172.25 million (Q4 2025) and $208.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Gossamer Bio | 46.08 Mn | -427.31 Mn | - | 76.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.87 Mn |
| Mar 31, 2026 | 128.90 Mn |
| Dec 31, 2025 | 172.25 Mn |
| Sep 30, 2025 | 208.82 Mn |
| Jun 30, 2025 | 240.93 Mn |
| Mar 31, 2025 | 280.59 Mn |
| Dec 31, 2024 | 315.29 Mn |
| Sep 30, 2024 | 350.88 Mn |
| Jun 30, 2024 | 373.45 Mn |
| Mar 31, 2024 | 259.36 Mn |
| Dec 31, 2023 | 311.92 Mn |
| Sep 30, 2023 | 347.93 Mn |
| Jun 30, 2023 | 181.75 Mn |
| Mar 31, 2023 | 219.91 Mn |
| Dec 31, 2022 | 272.45 Mn |
| Sep 30, 2022 | 323.54 Mn |
| Jun 30, 2022 | 245.84 Mn |
| Mar 31, 2022 | 294.68 Mn |
| Dec 31, 2021 | 343.66 Mn |
| Sep 30, 2021 | 387.04 Mn |
API Access
Gossamer Bio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();